YeaD is encoded by the yeaD gene (UniProt ID: P39139) in B. subtilis strain 168. It is classified as an "uncharacterized protein," meaning its specific biochemical or physiological role is not yet defined . Key features include:
Recombinant YeaD is synthesized using heterologous expression systems. For example:
Expression in *E. coli*: The gene is cloned into plasmids under strong promoters (e.g., T7), and the protein is purified via immobilized metal affinity chromatography (IMAC) due to His-tag fusion .
Yeast Systems: Alternative platforms like Pichia pastoris are used for eukaryotic post-translational modifications, though this is less common for bacterial proteins .
While direct functional data for YeaD are lacking, recombinant production facilitates:
Antibody Development: Used as an antigen to generate polyclonal or monoclonal antibodies for cellular localization studies .
Structural Biology: Crystallization trials to resolve its 3D architecture .
Interaction Studies: Screening for binding partners via pull-down assays or bacterial two-hybrid systems .
Similar uncharacterized proteins in B. subtilis, such as YlxR (renamed RnpM), have been found to modulate essential enzymes like RNase P, suggesting YeaD could play roles in RNA processing or stress response .
Functional Annotation: High-throughput mutagenesis or CRISPR-interference screens could link yeaD to specific phenotypes .
Secretion Pathways: Engineering B. subtilis secretion systems to overexpress YeaD natively, improving yield and post-translational accuracy .
Omics Integration: Proteomic and transcriptomic datasets from diamide-stressed B. subtilis (which upregulate stress-response proteins) may reveal YeaD’s role under specific conditions .
Studies on homologous proteins provide clues: